More advertisements and more information were reaching more patients than ever before
Several monoclonal antibody treatments have received Emergency Use Authorizations (EUAs) for IV use in specific populations
That means that if you weigh 200 lb, you could lose between 10 and 40 pounds
They are creating a new consumer. About 60% of GLP-1 users are women
Anti-apoptotic effects of GLP-1RAs In both diabetic and non-diabetic rodent models of cerebral ischemia, exenatide, lixisenatide, semaglutide, and liraglutide increased the expression of the anti-apoptotic factor B-cell lymphoma 2 (Bcl-2) and decreased the expression of the pro-apoptotic factor Bcl-2-associated X protein (Bax), consequently leading to a reduced Bax/Bcl-2 ratio and reduced apoptosis, possibly through ROS reduction and activation of the PI3K/Akt and MAPK pathways [73, 86, 87, 92, 93]